106
Participants
Start Date
August 31, 2001
Primary Completion Date
September 30, 2004
Study Completion Date
September 5, 2004
Fludarabine Phosphate
Given IV
Total-Body Irradiation
Undergo TBI
Peripheral Blood Stem Cell Transplantation
Undergo nonmyeloablative PBSCT
Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation
Undergo nonmyeloablative PBSCT
Cyclosporine
Given PO
Mycophenolate Mofetil
Given PO
University of Torino, Torino
Emory University/Winship Cancer Institute, Atlanta
Froedtert and the Medical College of Wisconsin, Milwaukee
Baylor Medical Center at Garland, Garland
Huntsman Cancer Institute/University of Utah, Salt Lake City
University of Arizona Health Sciences Center, Tucson
Stanford University Hospitals and Clinics, Stanford
OHSU Knight Cancer Institute, Portland
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium, Seattle
Universitaet Leipzig, Leipzig
National Heart, Lung, and Blood Institute (NHLBI)
NIH
National Cancer Institute (NCI)
NIH
Fred Hutchinson Cancer Center
OTHER